
TSE:L
This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is recognized as a dominant player in the Canadian grocery and pharmacy sector, benefiting from strong brand loyalty and private label offerings. Despite its robust performance, experts express concerns regarding its valuation, with some calling for caution due to the perception of shrinking growth potential and increased competition from retailers like Walmart and Costco. While some analysts view Loblaw as a defensive investment that could provide stability in uncertain economic times, others critique its recent price surges and suggest trimming positions. The company's acquisition of Shoppers Drug Mart is praised for unlocking profitability, though comparisons with ATD highlight some hesitancy among investors. Overall, while Loblaw has shown resilience amid food inflation, market sentiment varies, indicating mixed outlooks on its future performance.
This is a recent addition to their portfolio. Loblaw runs some dominant banners in both grocery retailing and pharmacy. Have accelerated their organic growth with the purchase of Shoppers Drugmart. They have gained market share and shown margin improvement. We like what they are doing operationally and financially. Stock is trading at 14X earnings. The value of growth and consistency in this name is exceptional. (Analysts’ price target is $76.92)
Reasonable in terms of a longer term outlook. They sell products that everyone needs: food, and pharmaceuticals and beauty products through Shoppers Drug Mart. Good positions and locations in both those segments, which are critical for those types of businesses. Experienced operators. The industry is in transition regarding goods delivery and pickup. They have click and collect, and have introduced online delivery. Some headwinds with minimum wage, which they’re now overcoming. Earnings growth not that stellar. Going forward earnings should be in mid to high single digit range. Stock is reasonably priced at around $65, with a bit of a yield.
He recently bought this. Cash flow and earnings have ticked up, though the stock has been sidways the past few years. They've done well integrating Shopper's Drug Mart. They are massively buying back stock. Also done well growing No Frills, a growth opportunity. A safe, defensive name with room to grow. Pays a 1.8% dividend.